Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning-Reference-Cited by-同舟云学术

Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning

Published:2019-01-08 Issue: Volume:6 Page:
ISSN:2296-2360
Container-title:Frontiers in Pediatrics
language:
Short-container-title:Front. Pediatr.

Author:

Valdez Ashley R.,Hancock Elizabeth E.,Adebayo Seyi,Kiernicki David J.,Proskauer Daniel,Attewell John R.,Bateman Lucinda,DeMaria Alfred,Lapp Charles W.,Rowe Peter C.,Proskauer Charmian

Publisher

Frontiers Media SA

Subject

Pediatrics, Perinatology, and Child Health

Reference30 articles.

1. Agency for Healthcare Research and Quality, Evidence Reports/Technology Assessments;Smith;Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome,2014

2. CFSAC Recommendations: Recommendations and Rationale from Working Group on IOM and P2P Reports-PDF2015

3. The search for pain relief in people with chronic fatigue syndrome: a descriptive study;Marshall;Physiother Theor Pract.,2011

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection;JAMA Network Open;2024-07-24

2. Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome;PLOS ONE;2024-07-23

3. Determining the societal value of a prospective drug for ME/CFS in Germany;PLOS ONE;2024-07-18

4. Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations;Journal of Translational Medicine;2024-07-05

5. Healthcare system barriers impacting the care of Canadians with myalgic encephalomyelitis: A scoping review;Journal of Evaluation in Clinical Practice;2024-06-21